The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease
Status:
Terminated
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to see if patients with chronic kidney disease have endothelial
cells that don't function properly, which is thought to be a marker for cardiovascular risk.
Endothelial cells line the heart and blood vessels. The investigators will treat your high
cholesterol with a cholesterol-lowering drug (atorvastatin, or Lipitor). They will determine
if this cholesterol lowering drug improves subjects' cholesterol as well as the function of
endothelial cells.